• Users Online: 295
  • Print this page
  • Email this page
Year : 2020  |  Volume : 10  |  Issue : 4  |  Page : 255-258

Intraocular pressure reduction in glaucoma: Does every mmHg count?

Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; NIHR Moorfields Biomedical Research Centre, London, United Kingdom

Correspondence Address:
Dr. Hari Jayaram
Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust, London
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjo.tjo_63_20

Rights and Permissions

The reduction of intraocular pressure is currently the only known modifiable risk factor for the treatment of Glaucoma, which is the leading cause of irreversible worldwide blindness. This concise review discusses the evidence underpinning the reduction of intraocular pressure in the treatment of glaucoma, the role of target intraocular pressure in clinical practice and appraises clinical data supporting the concept that every mmHg of intraocular pressure reduction is important in reducing the risk of developing glaucoma and the progression of existing disease. Every mmHg in IOP reduction is important, with evidence showing an impact on both functional and structural progression but does not however explain all glaucoma risk.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded158    
    Comments [Add]    

Recommend this journal